Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 1,562 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: method comparison Clear all

Conditions: Depression
Interventions: Transcranial Magnetic Simulation, Mixed reality neuronavigation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Breast Cancer
Interventions: Tomosynthesis, Conventional; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 35 Years and older · Female only
Enrollment: 496 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Barrett's Esophagus
Interventions: Radio-Frequency Ablation, Cryotherapy; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 99 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hernia
Interventions: Standardized tension-free herniorrhaphy with prosthesis; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 2,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 14
States / cities: Birmingham, Alabama • No. Little Rock, Arkansas • San Francisco, California + 11 more

Conditions: Autism Spectrum Disorder, Autism
Interventions: ASSIST; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Not listed
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Chicago, Illinois • Nashville, Tennessee • Madison, Wisconsin

Conditions: Asthma
Interventions: Computerized Decision support; Behavioral
Lead sponsor: Agency for Healthcare Research and Quality (AHRQ); Federal
Eligibility: 1 Year to 18 Years
Enrollment: 1,030 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hepatocellular Carcinoma
Interventions: liver biopsy, free-breathing MRI; Procedure · Device
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Attack
Interventions: Diffusion Weighted Imaging with MRI scans; Procedure
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Anesthesia
Interventions: IV placement using ultrasound guidance vs traditional method; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 667 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Peripherally Inserted Central Catheters
Interventions: PICC (Cook, Bard); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: MODERATE AND HIGH MYOPIA
Interventions: PRK, MMC PRK, LASEK; Procedure
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 21 Years and older
Enrollment: 960 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2004
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Cardiovascular Diseases, Coronary Disease, Heart Diseases
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 30 Years to 59 Years
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Porphyria Cutanea Tarda
Interventions: Hydroxychloroquine, Phlebotomy; Drug · Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2021
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Lethal Means Safety, Brief Intervention, Concern Significant Others
Interventions: The Family Firearms Secure storage Training (FFAST) Intervention, Health and Stress Counseling; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Endometrial Cancer
Interventions: sentinel lymph node detection, indocyanine green solution, isosulfan blue, sentinel lymph node biopsy; Procedure · Drug
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: New Haven, Connecticut • Columbus, Ohio

Conditions: Cervical Cancer
Interventions: Papanicolaou test, cytology specimen collection procedure, annual screening, colposcopic biopsy, comparison of screening methods; Other · Procedure
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days
Interventions: Smoflipid 20% (investigational lipid for parenteral nutrition), Intralipid® 20%; Drug
Lead sponsor: Fresenius Kabi; Industry
Eligibility: 0 Weeks and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 13
States / cities: Palo Alto, California • San Diego, California • New Haven, Connecticut + 8 more

Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer
Interventions: Interview, Questionnaire Administration; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Male only
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 325
States / cities: Phoenix, Arizona • Fort Smith, Arkansas • Hot Springs, Arkansas + 204 more

Conditions: Breast Cancer
Interventions: Automated Breast Ultrasound (ABUS) as an adjunct to digital screening mammography; Device
Lead sponsor: U-Systems, Inc.; Industry
Eligibility: 25 Years and older · Female only
Enrollment: 15,679 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 11
States / cities: Indio, California • Monterey, California • Washington D.C., District of Columbia + 8 more

Conditions: Stroke, Parkinson Disease, Multiple Sclerosis, Oropharyngeal Dysphagia, Alzheimer Disease, Dementia
Interventions: Dysphagia Detection System; Device
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 12
States / cities: Downey, California • Aurora, Colorado • Washington D.C., District of Columbia + 8 more

Conditions: Non-Small Cell Lung Carcinoma
Interventions: Albumin-bound paclitaxel, Paclitaxel, Carboplatin; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 1,052 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 31
States / cities: Huntsville, Alabama • Hot Springs, Arkansas • Little Rock, Arkansas + 27 more

Conditions: Patient Preference
Interventions: Dexamethasone, Standard of care surgery; Drug · Other
Lead sponsor: Ophthalmic Consultants of Long Island; Other
Eligibility: 22 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Garden City, New York

Conditions: Facial Aging
Interventions: Laser Treatment; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Lyndhurst, Ohio

Conditions: Hypertension, Diabetes Mellitus, Type 2
Interventions: Ertugliflozin, Hydrochlorothiazide 12.5mg, Microneurography, SKNA recordings, Static Handgrip, Post-handgrip forearm vascular occlusion, Testing of the Arterial Baroreflex Function; Drug · Device · Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 35 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of Depression

Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography

Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma

Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?

Advocating for Supports to Improve Service Transitions

An Electronic Decision Support Tool to Improve Outpatient Asthma Care

Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions

Efficacy of Non Contrast DWI(Diffusion Weighted Imaging) Imaging Compared to DMR-DE

Ultrasound Guided Peripheral IV Insertion

Comparison of an Antibiotic Impregnated PICC Catheter Versus a Regular PICC Catheter in a Tertiary Care Setting

A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia

Comparison of Two Methods to Diagnose Coronary Artery Disease

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

Testing Family Firearm Secure Storage Training (FFAST) to Prevent Suicide

Lymph Node Mapping in Patients With Endometrial Cancer

Comparison of Screening Tests in Detecting Cervical Neoplasia

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.

Videofluoroscopic Swallowing Study (VFSS)

Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

Laser Spot Treatment of Perioral Rhytids

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.